HSBC Holdings’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

HSBC Holdings’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53,835	Closed	-$594K	–	3083
2022 Q2	$594K	Sell	53,835 -83,275	-61%	-$998K	﹤0.01%	2229
2022 Q1	$2.24M	Buy	137,110 +44,337	+48%	+$1.14M	﹤0.01%	1557
2021 Q4	$4.4M	Sell	92,773 -4,710	-5%	-$283K	﹤0.01%	1321
2021 Q3	$7.07M	Buy	97,483 +54,532	+127%	+$3.94M	0.01%	1008
2021 Q2	$3.61M	Buy	42,951 +29,456	+218%	+$1.94M	﹤0.01%	1218
2021 Q1	$649K	Sell	13,495 -125	-0.9%	-$6.78K	﹤0.01%	1829
2020 Q4	$640K	Buy	13,620 +3	+0%	+$118	﹤0.01%	2010
2020 Q3	$628K	Buy	+13,617	New	+$449K	﹤0.01%	1794

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSBC Holdings's NBP Position: Q3 2022 in Review

HSBC Holdings sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 53,835 shares — an estimated $594K sold.

HSBC Holdings first reported a position in NBP in Q3 2020 and held it in 8 quarters. The position peaked at $7.07M in Q3 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

HSBC Holdings reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
HSBC Holdings sold 53,835 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $594K.
HSBC Holdings first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 8 quarters.
HSBC Holdings's NovaBridge Biosciences American Depositary Shares position peaked at $7.07M in Q3 2021.
75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.